Make Way for CalIBR | GenomeWeb

Make Way for CalIBR

Merck this week launched the California Institute for Biomedical Research, or CalIBR, "a new nonprofit research institute to help academics turn their basic biology insights into drug compounds ready for human tests," Science reports, adding that the pharmaceutical company is contributing $42 million over the first three years, and possibly as much as $90 million over the first seven years, to the institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.